Synonyms: AZD-6738 | AZD6738
Compound class:
Synthetic organic
Comment: Ceralasertib (AZD6738) is an orally available small molecule inhibitor of ATR serine/threonine kinase [1-2]. AZD6738 induces cell death and senescence in cancer cells in vitro and enhances the therapeutic efficacy of cisplatin in xenograft models. In vivo, combining AZD6738 with cisplatin destroys ATM-deficient lung cancer xenografts.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
In cellular assays AZD6738 inhibits ATR kinase-dependent CHK1 phosphorylation with an IC50 of 74nM [2]. In kinase screens of related PI3K, protein PI3K-like kinases and a wider panel of biochemical kinase assays, AZD6738 was found to inhibit PI3Kδ (IC50 6800nM), DYRK (IC50 10800nM) and PI3KC2G (20% inhibition at 1μM AZD6738). |
Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|